Transgenic Mice Secreting Coronavirus Neutralizing Antibodies into the Milk

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1998 Apr 29

PMID 9557658

Citations 28

Authors

I Sola

J Castilla

B Pintado

C B Whitelaw

A J Clark

L Enjuanes

Affiliations

Soon will be listed here.

Abstract

Ten lines of transgenic mice secreting transmissible gastroenteritis coronavirus (TGEV) neutralizing recombinant monoclonal antibodies (rMAbs) into the milk were generated. The rMAb light- and heavy-chain genes were assembled by fusing the genes encoding the variable modules of the murine MAb 6A.C3, which binds an interspecies conserved coronavirus epitope essential for virus infectivity, and a constant module from a porcine myeloma with the immunoglobulin A (IgA) isotype. The chimeric antibody led to dimer formation in the presence of J chain. The neutralization specific activity of the recombinant antibody produced in transiently or stably transformed cells was 50-fold higher than that of a monomeric rMAb with the IgG1 isotype and an identical binding site. This rMAb had titers of up to 10(4) by radioimmunoassay (RIA) and neutralized virus infectivity up to 10(4)-fold. Of 23 transgenic mice, 17 integrated both light and heavy chains, and at least 10 of them transmitted both genes to the progeny, leading to 100% of animals secreting functional TGEV neutralizing antibody during lactation. Selected mice produced milk with TGEV-specific antibody titers higher than 10(6) as determined by RIA, neutralized virus infectivity by 10(6)-fold, and produced up to 6 mg of antibody per ml. Antibody expression levels were transgene copy number independent and integration site dependent. Comicroinjection of the genomic beta-lactoglobulin gene with rMAb light- and heavy-chain genes led to the generation of transgenic mice carrying the three transgenes. The highest antibody titers were produced by transgenic mice that had integrated the antibody and beta-lactoglobulin genes, although the number of transgenic animals generated does not allow a definitive conclusion on the enhancing effect of beta-lactoglobulin cointegration. This approach may lead to the generation of transgenic animals providing lactogenic immunity to their progeny against enteric pathogens.

Citing Articles

Small Non-coding RNAs Associated with Viral Infectious Diseases of Veterinary Importance: Potential Clinical Applications.

Samir M, Pessler F Front Vet Sci. 2016; 3:22.

PMID: 27092305 PMC: 4819147. DOI: 10.3389/fvets.2016.00022.

(+)-Catechin inhibition of transmissible gastroenteritis coronavirus in swine testicular cells is involved its antioxidation.

Liang W, He L, Ning P, Lin J, Li H, Lin Z Res Vet Sci. 2015; 103:28-33.

PMID: 26679792 PMC: 7111882. DOI: 10.1016/j.rvsc.2015.09.009.

The history of monoclonal antibody development - Progress, remaining challenges and future innovations.

Liu J Ann Med Surg (Lond). 2015; 3(4):113-6.

PMID: 25568796 PMC: 4284445. DOI: 10.1016/j.amsu.2014.09.001.

High-dose dietary zinc oxide mitigates infection with transmissible gastroenteritis virus in piglets.

Chai W, Zakrzewski S, Gunzel D, Pieper R, Wang Z, Twardziok S BMC Vet Res. 2014; 10:75.

PMID: 24673930 PMC: 3986850. DOI: 10.1186/1746-6148-10-75.

Use of transgenic animals in biotechnology: prospects and problems.

Maksimenko O, Deykin A, Khodarovich Y, Georgiev P Acta Naturae. 2013; 5(1):33-46.

PMID: 23556129 PMC: 3612824.

References

Dimmock N . Neutralization of animal viruses. Curr Top Microbiol Immunol. 1993; 183:1-149. DOI: 10.1007/978-3-642-77849-0. View

Randall T, Parkhouse R, Corley R . J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5. Proc Natl Acad Sci U S A. 1992; 89(3):962-6. PMC: 48365. DOI: 10.1073/pnas.89.3.962. View

Wright G, Carver A, Cottom D, Reeves D, Scott A, Simons P . High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep. Biotechnology (N Y). 1991; 9(9):830-4. DOI: 10.1038/nbt0991-830. View

Whitelaw C, Archibald A, Harris S, McClenaghan M, Simons J, Clark A . Targeting expression to the mammary gland: intronic sequences can enhance the efficiency of gene expression in transgenic mice. Transgenic Res. 1991; 1(1):3-13. DOI: 10.1007/BF02512991. View

Simons J, McClenaghan M, Clark A . Alteration of the quality of milk by expression of sheep beta-lactoglobulin in transgenic mice. Nature. 1987; 328(6130):530-2. DOI: 10.1038/328530a0. View

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

Lammers B, Beaman K, Kim Y . Sequence analysis of porcine immunoglobulin light chain cDNAs. Mol Immunol. 1991; 28(8):877-80. DOI: 10.1016/0161-5890(91)90051-k. View

McClurkin A, NORMAN J . Studies on transmissible gastroenteritis of swine. II. Selected characteristics of a cytopathogenic virus common to five isolates from transmissible gastroenteritis. Can J Comp Med Vet Sci. 1966; 30(7):190-8. PMC: 1494555. View

Ali S, Clark A . Characterization of the gene encoding ovine beta-lactoglobulin. Similarity to the genes for retinol binding protein and other secretory proteins. J Mol Biol. 1988; 199(3):415-26. DOI: 10.1016/0022-2836(88)90614-6. View

10.

Fichot O, Girard M . An improved method for sequencing of RNA templates. Nucleic Acids Res. 1990; 18(20):6162. PMC: 332448. DOI: 10.1093/nar/18.20.6162. View

11.

Potter H, Weir L, Leder P . Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci U S A. 1984; 81(22):7161-5. PMC: 392097. DOI: 10.1073/pnas.81.22.7161. View

12.

Correa I, Gebauer F, Bullido M, Sune C, Baay M, Zwaagstra K . Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus. J Gen Virol. 1990; 71 ( Pt 2):271-9. DOI: 10.1099/0022-1317-71-2-271. View

13.

Castilla J, Sola I, Enjuanes L . Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies. J Virol. 1997; 71(7):5251-8. PMC: 191761. DOI: 10.1128/JVI.71.7.5251-5258.1997. View

14.

Clark A, Cowper A, Wallace R, Wright G, Simons J . Rescuing transgene expression by co-integration. Biotechnology (N Y). 1992; 10(11):1450-4. DOI: 10.1038/nbt1192-1450. View

15.

Weidle U, Lenz H, Brem G . Genes encoding a mouse monoclonal antibody are expressed in transgenic mice, rabbits and pigs. Gene. 1991; 98(2):185-91. DOI: 10.1016/0378-1119(91)90172-8. View

16.

Choi T, Huang M, Gorman C, Jaenisch R . A generic intron increases gene expression in transgenic mice. Mol Cell Biol. 1991; 11(6):3070-4. PMC: 360146. DOI: 10.1128/mcb.11.6.3070-3074.1991. View

17.

Sanchez C, Jimenez G, Laviada M, Correa I, Sune C, Bullido M . Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology. 1990; 174(2):410-7. PMC: 7130632. DOI: 10.1016/0042-6822(90)90094-8. View

18.

Limonta J, Pedraza A, Rodriguez A, Freyre F, BARRAL A, Castro F . Production of active anti-CD6 mouse/human chimeric antibodies in the milk of transgenic mice. Immunotechnology. 1995; 1(2):107-13. DOI: 10.1016/1380-2933(95)00010-0. View

19.

Amerongen H, Weltzin R, Mack J, Winner 3rd L, Michetti P, Apter F . M cell-mediated antigen transport and monoclonal IgA antibodies for mucosal immune protection. Ann N Y Acad Sci. 1992; 664:18-26. DOI: 10.1111/j.1749-6632.1992.tb39745.x. View

20.

Sune C, Jimenez G, Correa I, Bullido M, Gebauer F, Smerdou C . Mechanisms of transmissible gastroenteritis coronavirus neutralization. Virology. 1990; 177(2):559-69. PMC: 7131644. DOI: 10.1016/0042-6822(90)90521-r. View